Effect of Fentanyl on Pain Severity and Duration of Labor
This study has been terminated.
Information provided by (Responsible Party):
Nahid Jahani Shoorab, Mashhad University of Medical Sciences
First received: July 17, 2012
Last updated: July 23, 2012
Last verified: January 2006
Background: There are two methods of pharmacologic and non- pharmacologic for reducing pain of delivery. It is necessary to be known effect of these drugs on the mother and fetus during labor adverse. Therefore, the purpose of this study was determination of effect of Fentanyl intravenously on pain severity during the active phase of labor.
Decrease Labor Pain
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Primary Outcome Measures:
- decrease pain and duration of the active phase considerably. [ Time Frame: up to 8 months ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||August 2006 (Final data collection date for primary outcome measure)
In case group, 50 micrograms fentanyl was prescribed in two doses with an interval of 1 hour. In control group was not intervention.
In case group, 50 micrograms fentanyl was prescribed in two doses with an interval of 1 hour after being diluted in 4 cc normal saline
No Intervention: Without Fentanyl
The control group did not receive Fentanyl.
|Ages Eligible for Study:
||21 Years to 37 Years
|Genders Eligible for Study:
- multiparas pregnant women (gravid 2-7),
- term singleton pregnancy,
- cephalic presentation,
- low risk pregnancy with no history of drug tolerance (addiction),
- medical and mental diseases.
- Respiratory rate ≤ 8 or maternal bradycardia (pulse rate less than 60).
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
No Contacts or Locations Provided
No publications provided
||Nahid Jahani Shoorab, Faculty of Midwifery, Mashhad University of Medical Sciences
History of Changes
|Other Study ID Numbers:
||Effect of Fentanyl
|Study First Received:
||July 17, 2012
||July 23, 2012
||Iran: Ethics Committee
Keywords provided by Mashhad University of Medical Sciences:
duration of the active phase
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on April 23, 2015
Nervous System Diseases
Signs and Symptoms
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Physiological Effects of Drugs
Sensory System Agents